Five Key pillars

Our strategy is focused on 5 key pillars, incorporated in our culture and in our daily work.

  1. Development of a relevant portfolio of biosimilar products through our fully integrated R&D organization and facilities
  2. In house production of Drug Substance and Drug Product in state-of-the-art flexible bio-manufacturing facility
  3. Invest in highest quality and differentiation strategies to develop a value added and patient friendly product
  4. Leverage partnerships through Alvogen alliance and key global and strong local players to bring our high quality biosimilars to patients all around the world
  5. Attract best in class people and experienced leadership team to drive execution

Green energy provides almost

of Iceland’s electricity supply through hydro- and geothermal resources.

We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. Learn more.